The mediterranean paradox for susceptibility factors in coronary heart disease extends to genetics

Annals of Human Genetics

Volumn 72, Issue 1, 2008, Pages 48-56

  Lao, Oscar ^a   Dupanloup, Isabelle ^b,c   Barbujani, Guido ^c   Bertranpetit, Jaume ^a,d   Calafell, Francesc ^a,d,e  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF FERRARA   (Italy)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Complex disease; Coronary disease; Geneticrisk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE 1; BLOOD CLOTTING FACTOR 5; DIPEPTIDYL CARBOXYPEPTIDASE; GENE PRODUCT; PROTEIN AGT; PROTEIN SERPINE1; PROTHROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CORRELATION ANALYSIS; DNA POLYMORPHISM; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ALLELES; APOLIPOPROTEIN E4; CONFIDENCE INTERVALS; CORONARY DISEASE; DATABASES, FACTUAL; DISEASE SUSCEPTIBILITY; EUROPE; FEMALE; GENE FREQUENCY; GENETICS; GEOGRAPHY; HUMANS; INCIDENCE; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK FACTORS; VARIATION (GENETICS);

EID: 37849047424     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2007.00387.x     Document Type: Article

References (30)

1. Agerholm-Larsen, B., Nordestgaard, B.G. & Tybjaerg-Hansen, A. (2000) ACE gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 20, 484-92.
2. Barbujani, G. & Goldstein, D.B. (2004) Africans and asians abroad: genetic diversity in Europe. Annu Rev Genomics Hum Genet 5, 119-50.
3. Boekholdt, S.M., Bijsterveld, N.R., Moons, A.H., Levi, M., Buller, H.R. & Peters, R.J. (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: A systematic review. Circulation 104, 3063-8.
4. Burzotta, F., Paciaroni, K., De Stefano, V., Crea, F., Maseri, A., Leone, G. & Andreotti, F. (2004) G20210A prothrombin gene polymorphism and coronary ischaemic syndromes: A phenotype-specific meta-analysis of 12 034 subjects. Heart 90, 82-6.
5. Cavalli-Sforza, L.L., Menozzi, P. & Piazza, A. (1994) The history and geography of human genes. Princeton (NJ): Princeton University Press.
6. Dallongeville, J., Tiret, L., Visvikis, S., O'reilly, D.S., Saava, M., Tsitouris, G., Rosseneu, M., Debacker, G., Humphries, S.E. & Beisiegel, U. (1999) Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: The EARS II study. European Atherosclerosis Research Study. Atherosclerosis 145, 381-8.
7. Dupanloup, I., Bertorelle, G., Chikhi, L. & Barbujani, G. (2004) Estimating the impact of prehistoric admixture on the genome of europeans. Mol Biol Evol 21, 1361-72.
8. Excoffier, L., Laval, G. & Schneider, S. (2005) Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online 1, 47-50.
9. Excoffier, L., Smouse, P.E. & Quattro, J.M. (1992) Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 131, 479-491.
10. Gudnason, V., Stansbie, D., Scott, J., Bowron, A., Nicaud, V. & Humphries, S. (1998) C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis 136, 347-54.
11. Hair, J.F., Anderson, R.E., Tatham, R.L. & Black, W.C. (1998) Multivariate data analysis. Prentice Hall International, Inc.
12. Hirschhorn, J.N., Lohmueller, K., Byrne, E. & Hirschhorn, K. (2002) A comprehensive review of genetic association studies. Genet Med 4, 45-61.
13. Ioannidis, J.P., Ntzani, E.E. & Trikalinos, T.A. (2004) 'Racial'differences in genetic effects for complex diseases. Nat Genet 36, 1312-8.
14. Jamrozik, K., Spencer, C.A., Lawrence-Brown, M.M. & Norman, P.E.V. (2001) Does the Mediterranean paradox extend to abdominal aortic aneurysm? Int J Epidemiol 30, 1071-5.
15. Jobling, M., Hurles, M.E. & Tyler-Smith, C. (2004) Human evolutionary genetics. Origins, peoples & disease. New York: Garland Science.
16. Juhan-Vague, I., Morange, P.E., Frere, C., Aillaud, M.F., Alessi, M.C., Hawe, E., Boquist, S., Tornvall, P., Yudkin, J.S., Tremoli, E., Margaglione, M., Di Minno, G., Hamsten, A. & Humphries, S.E. (2003) The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: The HIFMECH study. J Thromb Haemost 1, 2322-9.
17. Juul, K., Tybjaerg-Hansen, A., Steffensen, R., Kofoed, S., Jensen, G. & Nordestgaard, B.G. (2002) Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood 100, 3-10.
18. Kato, N., Sugiyama, T., Morita, H., Kurihara, H., Yamori, Y. & Yazaki, Y. (1999) Angiotensinogen gene and essential hypertension in the Japanese: Extensive association study and meta-analysis on six reported studies. J Hypertens 17, 757-63.
19. Keavney, B. (2002) Genetic epidemiological studies of coronary heart disease. Int J Epidemiol 31, 730-6.
20. Kuulasmaa, K., Tunstall-Pedoe, H., Dobson, A., Fortmann, S., Sans, S., Tolonen, H., Evans, A., Ferrario, M. & Tuomilehto, J. (2000) Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355, 675-87.
21. Mackness, B., Davies, G.K., Turkie, W., Lee, E., Roberts, D.H., Hill, E., Roberts, C., Durrington, P.N. & Mackness, M.I. (2001) Paraoxonase status in coronary heart disease: Are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 21, 1451-7.
22. Muthumala, A., Cooper, J. & Humphries, S.E. (2006) European differences in the association between ACE I/D polymorphism and incidence of MI may be explained by gene-lipid interaction. Atherosclerosis 189, 474-7.
23. Schneider, S., Roessli, D. & Excoffier, L. (2000) Arlequin ver. 2.000: A software for population genetics data analysis.). Switzerland: Genetics and Biometry Laboratory, University of Geneva.
24. Sokal, R.R., Harding, R.M. & Oden, N.L. (1989) Spatial patterns of human gene frequencies in Europe. Am J Phys Anthropol 80, 267-94.
25. Stengard, J.H., Weiss, K.M. & Sing, C.F. (1998) An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet 103, 234-41.
26. Tunstall-Pedoe, H., Kuulasmaa, K., Mahonen, M., Tolonen, H., Ruokokoski, E. & Amouyel, P. (1999) Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353, 1547-57.
27. Wald, D.S., Law, M. & Morris, J.K. (2002) Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. Bmj 325, 1202.
28. Wilson, P.W., Schaefer, E.J., Larson, M.G. & Ordovas, J.M. (1996) Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 16, 1250-5.
29. Winkelmann, B.R. & Hager, J. (2000) Genetic variation in coronary heart disease and myocardial infarction: Methodological overview and clinical evidence. Pharmacogenomics 1, 73-94.
30. Young, R.P., Thomas, G.N., Critchley, J.A., Tomlinson, B., Woo, K.S. & Sanderson, J.E. (1998) Interethnic differences in coronary heart disease mortality in 25 population: Association with the angiotensin-converting enzyme DD genotype frequency. J. cardiovasc. Risk 5, 303-307.